bluebird bio, Inc.
BLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $80,806 | $1,969,184 | $10,876,164 | $13,768,218 |
| - Cash | $62,305 | $221,755 | $113,006 | $161,160 |
| + Debt | $358,238 | $330,326 | $367,058 | $89,584 |
| Enterprise Value | $376,739 | $2,077,755 | $11,130,216 | $13,696,642 |
| Revenue | $83,807 | $29,497 | $3,597 | $3,662 |
| % Growth | 184.1% | 720% | -1.8% | – |
| Gross Profit | -$5,573 | -$4,030 | -$6,480 | -$35,195 |
| % Margin | -6.6% | -13.7% | -180.2% | -961.1% |
| EBITDA | -$156,822 | -$167,161 | -$215,559 | -$556,926 |
| % Margin | -187.1% | -566.7% | -5,992.7% | -15,208.2% |
| Net Income | -$240,715 | -$211,913 | -$230,342 | -$819,378 |
| % Margin | -287.2% | -718.4% | -6,403.7% | -22,375.2% |
| EPS Diluted | -24.84 | -2.97 | -3.39 | -8.16 |
| % Growth | -736.4% | 12.4% | 58.5% | – |
| Operating Cash Flow | -$260,020 | -$235,046 | -$352,953 | -$635,639 |
| Capital Expenditures | -$2,599 | -$9,057 | -$13,208 | -$23,003 |
| Free Cash Flow | -$262,619 | -$244,103 | -$366,161 | -$658,642 |